The company hopes that once such gains can be shown with schizophrenia, similar training can be tested for other conditions, such as dementia and even among healthy individuals, said Henry Mahncke, chief executive of Posit Science.</p><p>I have no doubt we will succeed, but there are a lot of variables in these experiments that can decide the outcome, Merzenich said.